Related Experiment Videos
Prophylactic Nd:YAG-laser iridotomy versus surgical iridectomy: a randomized, prospective study
O Schwenn1, F Sell, N Pfeiffer
1Universitäts-Augenklinik, Mainz, Germany.
Summary
Nd:YAG-laser iridotomy and surgical iridectomy are equally effective for preventing angle-closure glaucoma regarding visual acuity and intraocular pressure. However, laser iridotomy offers better patient acceptance and preserves endothelial cell density, making it the preferred prophylactic method.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Innovation
Background:
- Angle-closure glaucoma poses a significant risk to vision.
- Both surgical iridectomy and Nd:YAG-laser iridotomy are established prophylactic treatments.
- Direct comparative data on the superiority of these procedures is limited.
Purpose of the Study:
- To compare the efficacy and patient acceptance of surgical iridectomy versus Nd:YAG-laser iridotomy.
- To evaluate the impact of each procedure on visual acuity, intraocular pressure, anterior chamber depth, and endothelial cell count.
- To determine the preferred method for acute angle-closure glaucoma prophylaxis.
Main Methods:
- Prospective randomized study involving 30 patients with acute angle-closure glaucoma.
- One eye treated with surgical iridectomy, the fellow eye with Nd:YAG-laser iridotomy.
- Follow-up examinations at 1, 6, and 12 months post-treatment.
Main Results:
- No significant differences in visual acuity or intraocular pressure between the two groups.
- Both procedures increased peripheral anterior chamber depth, improving gonioscopic visibility.
- Nd:YAG-laser iridotomy group maintained endothelial cell density, unlike surgical iridectomy group (slight decrease).
- Patients reported better subjective acceptance of Nd:YAG-laser iridotomy.
Conclusions:
- Surgical iridectomy and Nd:YAG-laser iridotomy are equivalent in managing intraocular pressure and visual acuity for angle-closure glaucoma.
- Nd:YAG-laser iridotomy is suggested as the preferable prophylactic method due to preserved endothelial cells and superior patient acceptance.